Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZAtm (vimseltinib), a kinase ...
Russian attackers were behind the hack of the European Medicines Agency EMA in 2020. They had “unauthorized access to ...
We recently published a list of 12 Best Italian Stocks to Buy in 2025. In this article, we are going to take a look at where ...
The European Medicines Agency said the portal will enable consultations with medical device expert panels that can promote faster access to new technologies.
3d
GlobalData on MSNEMA establish advisory portal for high-risk medical devicesThe EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.
For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...
The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.
President Trump on Friday vowed to impose sweeping tariffs on semiconductor chips, pharmaceuticals, steel and aluminum and oil and gas. “We’ll be doing pharmaceuticals. Importantly in ...
Data from INAVO120, recently published in the New England Journal of Medicine, are also being reviewed by other global health authorities, including the European Medicines Agency. Itovebi is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results